Company Profiles

driven by the PitchBook Platform

Alpha Cancer Technologies

Description

Developer of chemotherapeutic drugs designed to identify and cure oncology and auto-immune disease indications. The company's chemotherapeutic drugs use targeted chemotherapy delivery platform that recombines human Alpha Fetoprotein, a shuttle protein that targets AFP receptors to enhance the performance of chemotherapy at lower dose, enabling patients to avail the treatment without any toxic effects.

2008

Founded

PRIVATE

Status

1-10

Employees

Later Stage VC

Latest Deal Type

$7.5M

Latest Deal Amount

$9.6M

Total Amount Raised

Description

Developer of chemotherapeutic drugs designed to identify and cure oncology and auto-immune disease indications. The company's chemotherapeutic drugs use targeted chemotherapy delivery platform that recombines human Alpha Fetoprotein, a shuttle protein that targets AFP receptors to enhance the performance of chemotherapy at lower dose, enabling patients to avail the treatment without any toxic effects.

Website:

www.alpha-cancer.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Biotechnology
Pharmaceuticals

Primary Office

MaRS Center, South Tower 200-101 College Street Toronto, Ontario M5G 1L7Canada +1 (416) 826-6626
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Alpha Cancer Technologies's full profile, request a free trial.

    Alpha Cancer Technologies Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Alpha Cancer Technologies Investors (3)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Federal Economic Development Agency for Southern OntarioGovernment000 0000000 0000
    Innovation Grade VenturesVenture CapitalMinority000 0000000 0000
    XDL Angel GroupAngel (individual)Minority000 0000000 0000
    Federal Economic Development Agency for Southern Ontario Government
    Innovation Grade Ventures Venture Capital
    XDL Angel Group Angel (individual)

    Alpha Cancer Technologies Executive Team (1)

    NameTitleBoard
    Seat
    Contact
    Info
    Igor Sherman Ph.DChief Executive Officer, President & Founder
    Igor Sherman Ph.D Chief Executive Officer, President & Founder

    Alpha Cancer Technologies Board Members (4)

    NameRepresentingRoleSinceContact
    Info
    Borys ChaburskySelfBoard Member000 0000
    Christopher MorgonSelfBoard Member000 0000
    Jeffrey PurittSelfBoard Member000 0000
    Richard PottsSelfChairman000 0000
    Borys Chabursky Board Member Self
    Christopher Morgon Board Member Self
    Jeffrey Puritt Board Member Self
    Richard Potts Chairman Self
    Request full access to PitchBook